Etoricoxib Coated Tablets: Bioequivalence Assessment between Two Formulations Administered under Fasting Conditions
Etoricoxib is a non-steroidal anti-inflammatory drug with high selectivity for cyclooxygenase 2 (COX-2), exerting a pronounced anti-inflammatory effect with fewer adverse events when compared to COX-1 inhibitors. The present study aimed to evaluate the bioequivalence between two etoricoxib-coated ta...
Main Authors: | Jessica Meulman, Marcelo Gomes Davanço, Débora Renz Barreto Vianna, Thalita Martins da Silva, Fernando Costa, Fernando Bastos Canton Pacheco, Milla Emke de Oliveira, Celso Francisco Pimentel Vespasiano |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-11-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/15/11/2569 |
Similar Items
-
Pharmacokinetic equivalence study of nonsteroidal anti-inflammatory drug etoricoxib
by: Tjandrawinata RR, et al.
Published: (2018-04-01) -
Methylphenidate Multiphasic Release Tablet: Bioequivalence Assessment between Two Formulations Administered under Fasting and Fed Conditions
by: Marcelo Gomes Davanço, et al.
Published: (2023-06-01) -
Fast and Sensitive HPLC-ESI-MS/MS Method for Etoricoxib Quantification in Human Plasma and Application to Bioequivalence Study
by: Gabriel Onn Kit Loh, et al.
Published: (2022-09-01) -
Bioequivalence clinical trial simulation: a case study of apalutamide administered in applesauce versus whole tablets
by: Alex Yu, et al.
Published: (2023-08-01) -
Comparison of etoricoxib and indomethacin for the treatment of experimental periodontitis in rats
by: M.C.F. Azoubel, et al.
Published: (2007-01-01)